Zepbound Dosage Chart 2026: Approved Schedule, KwikPen Strengths, and Titration Rules

The complete Zepbound (tirzepatide, weight-management brand) dosage schedule: the six KwikPen strengths, four-week titration, missed-dose window, and how it differs from Mounjaro and Wegovy.

The Approved Zepbound Schedule

Zepbound is tirzepatide dosed for chronic weight management: once-weekly subcutaneous injection titrated from 2.5 mg (weeks 1-4) through 5 mg, 7.5 mg, 10 mg, and 12.5 mg in four-week steps, up to 15 mg maintenance — the same ladder as Mounjaro because it is the same molecule. The "how often to inject" answer is once weekly, same day each week, with or without food. The 2.5 mg step is deliberately subtherapeutic — it is the tolerability ramp for the class's GI effects, and skipping it is how people end up needing to pause. Our tirzepatide calculator encodes the full ladder for protocol math.

KwikPen Strengths and Delivery

Zepbound ships in the six KwikPen strengths matching the schedule (2.5 through 15 mg), each delivering four weekly doses, plus a vial format used under pharmacy rules that were narrowed when the tirzepatide shortage status ended. Delivery notes that matter: KwikPens are single-patient devices, doses are fixed per pen strength, and the "how many units is 7.5 mg" style questions that flood forums usually come from vial users doing the mg-to-insulin-syringe conversion — our unit converter exists for exactly that math, and the reconstitution guide covers diluent choices for research contexts. Pen pricing runs the same across strengths, so the cost variable is treatment duration, not dose level — our cost comparison tracks the programs.

Titration, Missed Doses, and Side-Effect Management

The four-week steps exist because dose-response in tirzepatide is strong: trial weight loss scaled from ~15% at 5 mg toward ~21% at 15 mg, and GI effects scale with dose in the escalation weeks. Missed-dose rule: take within 96 hours (4 days) if remembered, otherwise skip and resume on the weekly schedule; after two missed doses, contact the prescriber about re-titration — this is the label rule that the active gastroparesis litigation has made more important to follow, not less. Nausea management per the label: small meals, slower escalation, and prescriber contact for persistent symptoms. The same discipline appears in our research calculators: the ladder is the data, and shortcuts in titration are where the safety margin erodes.

Zepbound in the 2026 Landscape

Zepbound (tirzepatide) is the efficacy leader among approved GLP-1 options: ahead of Wegovy (semaglutide, ~15%) on trial weight loss, behind investigational retatrutide (up to 31% in TRIUMPH), and now sharing the market with the first oral option (orforglipron) at the convenience tier. The active lawsuits over claimed serious side effects are the 2026 storyline our news section tracks; the dosing discipline the litigation underscores is the same one the titration ladder encodes. For researchers comparing molecules, our semaglutide-vs-tirzepatide guide is the head-to-head reference, and the calculator set covers every approved and investigational ladder in the class.

📊 Dosage Calculator & Protocol Chart

Use our free Zepbound dosage calculator to plan your protocol:

👉 Zepbound Dosage Calculator — Calculate exact dosing, reconstitution ratios, and injection volumes.

👉 Full Dosing Guide & Protocol Chart — Complete protocol with weekly titration schedule, side effect management, and cycle recommendations.

Important Disclaimer

This article is for educational and research purposes only. Peptides discussed may not be FDA-approved for all uses described. Always consult with a qualified healthcare provider before starting any peptide protocol. The information provided here is synthesized from published research, clinical trial data, and community discussions.

Keywords: zepbound dosage chart, zepbound how often to inject, zepound dosing, zepbound kwikpen, tirzepatide weight loss dose

Sources: Published research papers, clinical trial databases, community discussions, peptiq.io educational content